News

GrubMarket raises $60M as food delivery stays center stage

Veem Secures $31M in Strategic Funding Round

Boehringer Ingelheim Acquires Northern Biologics’ Preclinical Cancer Antibody Pipeline

Monte Rosa Therapeutics Announces $96 Million Series B Financing to Advance Protein Degradation Platform

Antios Therapeutics Announces Publication Describing Preclinical Profile

Northern Biologics reports the Phase 1 Dose Escalation of MSC-1, a humanized anti-LIF monoclonal antibody

Libra Launches with $29M Series A to Develop Novel Therapeutics for Neurodegenerative Diseases

UCB acquires Engage Therapeutics

Schrödinger Announces Expanded Collaboration with AstraZeneca

Connect Easier. Move Faster. Live Longer.

Sixty Degree Capital Inc. © 2020